Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Merck Q3 results: 5% revenue growth primarily driven by oncology

pharmaceutical-technologyOctober 29, 2018

Tag: Merck , Oncology , Pharmaceutical Company , Growth

PharmaSources Customer Service